Stone Clinical Laboratories, a leading full-service, boutique reference laboratory with facilities in Louisiana and Florida, announced today that it has entered into an in-network provider agreement with UnitedHealthcare, effective June 1, 2019.
This contract, along with other recently-signed and upcoming contracts, confirms Stone Clinical Laboratories’ established high payor acceptance rate, which it attributes to the quality of its science, the strength of its clinical programs, and its industry-leading customer care and support.
“This in-network agreement with UnitedHealthcare signifies the strength of Stone Clinical Laboratories’ unique medical leadership philosophy that synthesizes the values of providing comprehensive, responsive laboratory services and continuity of care for patients with innovative technologies to support physicians and healthcare providers,” said Christopher Ridgeway, founder and CEO of Stone Clinical Laboratories.
“We are committed to increasing access to our best-in-class technologies, expanding our reach by forming new partnerships, and developing reimbursement strategies that grow the availability of our offerings. With UnitedHealthcare now on board, we are proud to exceed the 100-million-covered-lives mark among payors supporting a direct relationship with our labs. UnitedHealthcare https://www.uhc.com/ joins Aetna, Humana, BCBS of Louisiana, BCBS of Texas, BCBS of Illinois, BCBS of Arizona, and numerous other regional payors in partnering with Stone Clinical Laboratories.”
Stone Clinical Laboratories’ testing platforms enable highly-accurate laboratory and molecular testing in patients. These advantages, combined with a world-class care environment and exceptional customer support, have established the company as a leader among the nation’s reference laboratories, and a reliable partner for patients, physicians and managed-care organizations.